Sponsor

Bangladesh Institute of Research and Rehabilitation in Diabetes, Endocrine and Metabolic Disorders

Clinical research sponsor

Published trials5

Recruiting shown0

Roles2

SourceClinicalTrials.gov

Clinical trials

5 shown

Real-World Evaluation of Omarigliptin for Type 2 Diabetes Meliitus in BangladeshNCT06449235 · lead sponsor · 2024-09-01

UNKNOWN

Prevalence and Management Practice of Diabetic Kidney Disease at BADAS Affiliated Healthcare Centres in BangladeshNCT06422598 · lead sponsor · 2024-05-11

UNKNOWN

Baricitinib in Hospitalized Covid-19 Patients With Diabetes MellitusNCT04970719 · lead sponsor · 2021-07-10

WITHDRAWN

Evaluating the Impact of Introducing Basaglar, a Long-acting Analog Insulin, on Clinical and Quality of Life Outcomes in Youth with Diabetes in BangladeshNCT06674135 · collaborator · 2022-06-01

COMPLETED

Efficacy Study of Pioglitazone and Metformin and Association Between Pioglitazone Response and Peroxisome Proliferator-activated Receptor Gamma Gene Variants in Bangladeshi Type 2 Diabetes Mellitus SubjectsNCT01589445 · collaborator · 2008-11-01

COMPLETED

Sponsor roles

lead sponsor3

collaborator2

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.